- Details
- Written by Angie Murad
- Category: Health News
Scottsdale, Arizona - Your body needs some fat to function normally. However, not all fats are created equal, and it’s wise to choose the healthier options whenever possible.
- Details
- Written by Vivien Williams
- Category: Health News
Rochester, Minnesota - There is no cure for Alzheimer's disease. But, over the past decade, researchers have learned a lot about factors that may contribute to the disease. This information, says Dr. Ronald Petersen, a Mayo Clinic neurologist, may aid in developing new treatments to help people with Alzheimer's disease live better lives.
- Details
- Written by Mayo Clinic
- Category: Health News
Scottsdale, Arizona - You know that exercise does your body good, but you're too busy and stressed to fit it into your routine. Hold on a second - there's good news when it comes to exercise and stress.
- Details
- Written by IVPost
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+). Ogivri is the first biosimilar approved in the U.S. for the treatment of breast cancer or stomach cancer and the second biosimilar approved in the U.S. for the treatment of cancer.
- Details
- Written by USDA
- Category: Health News
Washington, DC - Caesar's Pasta, LLC, a Blackwood, N.J. establishment, is recalling approximately 46,810 pounds of beef meatball products due to misbranding and undeclared allergens, the U.S. Department of Agriculture’s Food Safety and Inspection Service (FSIS) announced today. The products contain egg, a known allergen, which is not declared on the product label.
- Details
- Written by IVN
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration approved Sublocade, the first once-monthly injectable buprenorphine product for the treatment of moderate-to-severe opioid use disorder (OUD) in adult patients who have initiated treatment with a transmucosal (absorbed through mucus membrane) buprenorphine-containing product. It is indicated for patients that have been on a stable dose of buprenorphine treatment for a minimum of seven days.
Page 53 of 374
